Sort   by:  
 Page size 
UnknownMAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.
Not available
S-EPMC4401580 | biostudies-literature
UnknownALK mutations conferring differential resistance to structurally diverse ALK inhibitors.
Not available
S-EPMC3382103 | biostudies-literature
UnknownOptimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer.
Not available
S-EPMC4338015 | biostudies-literature
UnknownImproved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.
Not available
S-EPMC6823126 | biostudies-literature
UnknownTargeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer.
Not available
S-EPMC4086149 | biostudies-literature
UnknownRoutine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
Not available
S-EPMC3335021 | biostudies-literature
UnknownMonitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.
Not available
S-EPMC6823161 | biostudies-literature
UnknownROS1 rearrangements define a unique molecular class of lung cancers.
Not available
S-EPMC3295572 | biostudies-literature
UnknownGenomic Landscapes and Hallmarks of Mutant RAS in Human Cancers.
Not available
S-EPMC9627127 | biostudies-literature
UnknownThe Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
Not available
S-EPMC6964135 | biostudies-literature
Sort   by:  
 Page size